Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy (CRT) for Patients with Locally Advanced Non–small-cell Lung Cancer (LANSCLC): A Phase I Trial
2009 ◽
Vol 75
(3)
◽
pp. S110
◽
Keyword(s):
Phase I
◽